Dingdang Medicine Express and Meinian Onehealth launch a new Covid-19 test service

On April 24, Dingdang Express, a pharmaceutical New-Retail company, announced the launch of a new nucleic acid testing service for coronary virus with Mega Genomics, a subsidiary of Meinian Onehealth, to help citizens and businesses in cities resume work.

On April 24, Dingdang Medicine Express, a pharmaceutical New-Retail company, announced the launch of a new nucleic acid testing service for coronary virus with Mega Genomics, a subsidiary of Meinian Onehealth, to help citizens and businesses in cities resume work.

Citizens from 10 cities including Beijing, Hangzhou, Guangzhou, Chengdu, Nanjing, and Shenzhen can search and reserve the service at Dingdang Medicine Express, which provide testing services by professional institutions with relevant qualifications, and obtain electronic report within 24 hours at the earliest.

In addition, within the next week, the nucleic acid testing appointment service of the Dingdang Medicine Express platform will also be launched in 28 cities including Tianjin, Wuhan, Dongguan, Foshan, Nanchang, Xiamen, Shenyang, Harbin, Shijiazhuang, Changsha, Zhengzhou, Chongqing and Guiyang.

In addition to the first 10 cities opened, there are 38 cities that support the appointment service of nucleic acid detection.

The results of the user test report can be queried on the WeChat public account of Mega Genomics.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/04/27/dingdang-medicine-express-and-meinian-onehealth-launch-a-new-covid-19-test-service/.

Leave a Reply

Please Login to Comment